Protagenic Therapeutics, Inc.\new (PTIX)
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Protagenic Therapeutics, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 1.81M shares outstanding
USProtagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders.
Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses.
The company is based in New York, New York.
Leadership
Alexander K. Arrow
Chief Financial Officer
Andrew Slee
Chief Development Officer
Garo H. Armen
Executive Chairman
Robert B. Stein
Director, Chief Medical Officer
Employees
1
Country
US
Sector
Healthcare
Website
protagenic.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF. | Purchase | 20.0K | $13.0K | Aug 21, 2026 |
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF. | Purchase | 16.6K | $9.8K | Aug 20, 2026 |
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF. | Purchase | 2.7K | $945 | Aug 19, 2026 |
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF. | Purchase | 2.2K | $710.4 | Aug 11, 2026 |
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF. | Purchase | 685 | $150.7 | Aug 6, 2026 |
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF. | Purchase | 5.0K | $1.3K | Aug 5, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
 ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF., Director | 73.5K | 4.1% | FORM 4 |
DRW Securities, LLC | 41.8K | 2.3% | 13F |
FNY Investment Advisers, LLC | 25.0K | 1.4% | 13F |
Armistice Capital, LLC · may incl. warrants· filed Feb 2025 | 17.1K | 0.9% | 13G |
 EVANS BARRETT ex CEO, Director, 10% Owner | 1.0K | 0.1% | FORM 4 |
Insiders
- ARMEN GARO HEXEC. CHAIR & PRINCIPAL OFF.
- EVANS BARRETTex CEO, Director, 10% Owner
Top institutional holders
based on 1.81M shares outstanding
US30d Avg
1.38K
60d Avg
7.11K
90d Avg
14.89K